Forecast: Basic Pharmaceutical Products Production Value in Poland

The production value of basic pharmaceutical products in Poland was subject to significant fluctuations from 2013 to 2023. The highest value was recorded in 2016 at 185.6 million euros, before experiencing a steep decline and notable volatility in subsequent years. In 2023, the production value stood at 85.9 million euros, representing a 4.98% decrease from the previous year. From 2018 to 2023, the compounded annual growth rate (CAGR) was approximately -1.01% indicating an overall downward trend.

Future forecasts show a continued decline with an estimated decrease to 70.3 million euros by 2028, reflecting a forecasted 5-year CAGR of -3.03%. The trend over these years reveals a compound decline with some stabilizations and recoveries amidst the general downturn.

Future trends to watch for include potential market consolidations, advancements in pharmaceutical technology, changes in regulatory policies which may influence production efficiency, and potential shifts in global and local demand for basic pharmaceuticals.